FDA Recalls Mislabelled Eszopiclone Tablets Distributed by Aidapak Services
Aidapak Services is recalling Eszopiclone 3 mg tablets that may be mislabeled as Cholecalciferol 1000 units. The error involves specific pedigree and expiration codes.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a labeling mixup, which is a moderate risk compared to contamination or structural defects.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for Eszopiclone, Tablet, 3 mg, distributed by Aidapak Services, LLC. The recall is due to a labeling mixup where the medication may be incorrectly labeled as Cholecalciferol, Tablet, 1000 units.
The affected product is identified by the NDC 63402019310, with a pedigree code of W002765 and an expiration date of 6/6/2014. The mislabeling risk involves the product being confused with Cholecalciferol, Tablet, 1000 units (NDC 00904582460), which has a pedigree code of W002779 and the same expiration date of 6/6/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers and healthcare providers should check their inventory for these specific codes. If the product matches the description, it should be returned to the distributor or a local pharmacy for disposal. Patients should consult their healthcare provider if they have taken the medication and have concerns about the labeling error.
The recalled product
- Product
- ESZOPICLONE, Tablet, 3 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63402019310
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- ESZOPICLONE
- Tablet
- 3 mg has the following code Pedigree: W002765
- EXP: 6/6/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02